Institutional Ownership Adaptimmune Therapeutics PLC (ADAP)
This table provides information about the institutional ownership of Adaptimmune Therapeutics PLC (ADAP). We have compiled data on the 83 institutions that hold shares in the stock, with a total of 123 Million shares, which have been reported (via 13F filing form) to have a value of $56.5 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Virtu Financial LLC
New York, NY |
Feb 11, 2025 Q4 2024 |
122,696
shares
|
$56,440
0.0% of portfolio
|
Q4 2024
Added 21.47%
|
|
|
Act Capital Management, LLC
Wayne, PA |
Nov 03, 2022 Q3 2022 |
90,000
shares
|
$41,400
0.13% of portfolio
|
Q3 2021
New holding
|
|
|
Hrt Financial LP
New York, NY |
Feb 14, 2025 Q4 2024 |
83,199
shares
|
$38,271
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Captrust Financial Advisors
Raleigh, NC |
Feb 14, 2025 Q4 2024 |
81,629
shares
|
$37,549
0.0% of portfolio
|
Q4 2024
Reduced 1.7%
|
|
|
Two Sigma Investments, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
76,347
shares
|
$35,119
0.0% of portfolio
|
Q4 2024
Added 33.47%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Feb 14, 2025 Q4 2024 |
70,735
shares
|
$32,538
0.0% of portfolio
|
Q4 2024
Added 492.02%
|
|
|
Wells Fargo & Company
San Francisco, CA |
Feb 12, 2025 Q4 2024 |
63,967
shares
|
$29,424
0.0% of portfolio
|
Q4 2024
Reduced 4.27%
|
|
|
Invesco Ltd.
Atlanta, GA |
Feb 13, 2025 Q4 2024 |
63,335
shares
|
$29,134
0.0% of portfolio
|
Q4 2024
Added 81.95%
|
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
51,333
shares
|
$23,613
0.0% of portfolio
|
Q3 2024
Reduced 1.02%
|
|
|
Barclays PLC
London, X0 |
Feb 13, 2025 Q4 2024 |
50,061
shares
|
$23,028
0.0% of portfolio
|
Q2 2023
New holding
|
|
|
Palisades Investment Partners, LLC
Santa Monica, CA |
Feb 18, 2025 Q4 2024 |
47,114
shares
|
$21,672
0.01% of portfolio
|
Q4 2024
Added 8.42%
|
|
|
Vontobel Holding Ltd.
|
Jan 29, 2025 Q4 2024 |
43,000
shares
|
$19,780
0.0% of portfolio
|
Q3 2024
Added 230.77%
|
|
|
Graham Capital Management, L.P.
Rowayton, CT |
Feb 14, 2025 Q4 2024 |
37,195
shares
|
$17,109
0.0% of portfolio
|
Q4 2024
Added 195.39%
|
|
|
Oppenheimer & CO Inc
New York, NY |
Feb 04, 2025 Q4 2024 |
32,043
shares
|
$14,739
0.0% of portfolio
|
Q4 2024
Reduced 11.67%
|
|
|
Raymond James Financial Inc
St. Petersburg, FL |
Feb 06, 2025 Q4 2024 |
31,081
shares
|
$14,297
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Css LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
30,702
shares
|
$14,122
0.0% of portfolio
|
Q4 2023
Reduced 66.15%
|
|
|
Simon Quick Advisors, LLC
|
Jan 17, 2025 Q4 2024 |
30,000
shares
|
$13,800
0.0% of portfolio
|
Q4 2024
Reduced 1.48%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Feb 14, 2025 Q4 2024 |
29,559
shares
|
$13,597
0.0% of portfolio
|
Q4 2024
Reduced 95.87%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Feb 14, 2025 Q4 2024 |
29,150
shares
|
$13,409
0.0% of portfolio
|
Q4 2024
Reduced 84.62%
|
|
|
Newman Dignan & Sheerar, Inc.
|
Jan 30, 2025 Q4 2024 |
27,957
shares
|
$12,860
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Wealth Enhancement Advisory Services, LLC
|
Mar 17, 2025 Q4 2024 |
26,816
shares
|
$12,335
0.0% of portfolio
|
Q4 2024
Added 147.93%
|
|
|
Stifel Financial Corp
St. Louis, MO |
Feb 13, 2025 Q4 2024 |
26,469
shares
|
$12,175
0.0% of portfolio
|
Q4 2024
Reduced 4.16%
|
|
|
Hsbc Holdings PLC
London, X0 |
Feb 14, 2025 Q4 2024 |
26,064
shares
|
$11,989
0.0% of portfolio
|
Q1 2024
Reduced 1.66%
|
|
|
Hunter Associates Investment Management LLC
Pittsburgh, PA |
Jan 23, 2025 Q4 2024 |
22,000
shares
|
$10,120
0.0% of portfolio
|
Q4 2024
Reduced 4.35%
|
|
|
Prosperity Wealth Management, Inc.
San Ramon, CA |
Feb 07, 2025 Q4 2024 |
21,870
shares
|
$10,060
0.0% of portfolio
|
Q4 2024
Reduced 11.17%
|